K5A-20853-16116
2 vaccinations
4 coded responses
24 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 148 / NY
- Registered
- 2021-11-12
- Relationship
- Child or adolescent in my care
- Guardian
- CXG-31721-37428
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-11-12
Registered in v-safe
-
2021-11-12
Dose 1 — Pfizer-BioNTech
-
2021-11-12
Survey response — day 0, dose 1, dependentMedDRA: Unevaluable event — Feeling: GoodFree text: (b)(6) has been very loud todayMedDRA releases: 2024-11 · check-in free text available
- 2021-11-13
- 2021-11-15
- 2021-11-16
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-26
-
2021-12-03
Dose 2 — Pfizer-BioNTech
- 2021-12-03
-
2021-12-04
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2021-12-05
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-12-06
- 2021-12-07
- 2021-12-08
- 2021-12-09
- 2021-12-10
- 2021-12-17
-
2021-12-24
Survey response — day 21, dose 2, dependentMedDRA: Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend schoolFree text: A cold. Runny nose, congestion. Tested negative for covid.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-02
- 2022-01-07
-
2022-01-14
Survey response — day 42, dose 2, dependentMedDRA: Decreased appetite, Diarrhoea, Fatigue, Gastroenteritis, Lethargy, Pyrexia, Vomiting — Feeling: Good · Be unable to work or attend schoolFree text: Likely gastroenteritis. Vomiting, diarrhea, fever, lethargy, fatigue, anorexia. These symptoms lasted about 4-5 days before a complete recovery.MedDRA releases: 2024-11 · check-in free text available
- 2022-03-04
-
2022-06-05
Survey response — 6 months, dose 2, dependentMedDRA: Nasopharyngitis, Respiratory tract congestion — Feeling: FairFree text: Congestion, common cold symptomsMedDRA releases: 2024-11 · check-in free text available
- 2022-12-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-12 | Pfizer-BioNTech | No |
| 2 | 2021-12-03 | Pfizer-BioNTech | No |
Free text
Release 10 — day 0, dose 1, dependent
Release 10 — day 21, dose 2, dependent
Symptoms: A cold. Runny nose, congestion. Tested negative for covid.
Release 10 — day 42, dose 2, dependent
Symptoms: Likely gastroenteritis. Vomiting, diarrhea, fever, lethargy, fatigue, anorexia. These symptoms lasted about 4-5 days before a complete recovery.
Release 11 — 6 months, dose 2, dependent
Symptoms: Congestion, common cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Decreased appetite | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gastroenteritis | · | · | ✓ |
| SD | Lethargy | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release